Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $6000.0.

  • Gossamer Bio's Depreciation & Amortization (CF) fell 9700.0% to $6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $126000.0, marking a year-over-year decrease of 8801.14%. This contributed to the annual value of $833000.0 for FY2024, which is 4816.43% down from last year.
  • Per Gossamer Bio's latest filing, its Depreciation & Amortization (CF) stood at $6000.0 for Q3 2025, which was down 9700.0% from $6000.0 recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Depreciation & Amortization (CF) peaked at $500000.0 during Q1 2022, and registered a low of $6000.0 during Q1 2025.
  • For the 4-year period, Gossamer Bio's Depreciation & Amortization (CF) averaged around $300600.0, with its median value being $300000.0 (2024).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first changed by 0.0% in 2023, then plummeted by 9800.0% in 2025.
  • Over the past 4 years, Gossamer Bio's Depreciation & Amortization (CF) (Quarter) stood at $432000.0 in 2022, then crashed by 32.41% to $292000.0 in 2023, then crashed by 63.01% to $108000.0 in 2024, then crashed by 94.44% to $6000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $6000.0 for Q3 2025, versus $6000.0 for Q2 2025 and $6000.0 for Q1 2025.